0,929  0,003  Antineoplastic (cervical cancer)
0,928  0,004  Antineoplastic (breast cancer)
0,923  0,005  Antiinflammatory
0,903  0,004  Antineoplastic (colorectal cancer)
0,900  0,004  Antineoplastic (colon cancer)
0,867  0,005  Antineoplastic (lung cancer)
0,849  0,004  Nitric oxide antagonist
0,813  0,004  Antineoplastic (glioma)
0,804  0,005  Respiratory analeptic
0,798  0,002  UGT1A4 substrate
0,808  0,012  Transcription factor NF kappa B inhibitor
0,795  0,004  Antineoplastic (glioblastoma multiforme)
0,787  0,005  Analeptic
0,789  0,018  Apoptosis agonist
0,779  0,011  CYP3A4 substrate
0,777  0,009  TNF expression inhibitor
0,771  0,004  UDP-glucuronosyltransferase substrate
0,770  0,005  Cholesterol antagonist
0,764  0,004  Antineoplastic (brain cancer)
0,755  0,006  Sensitization
0,748  0,009  Antileukemic
0,735  0,013  Teratogen
0,724  0,013  Embryotoxic
0,682  0,007  NOS3 expression inhibitor
0,676  0,004  Antipruritic, allergic
0,678  0,012  Antihypercholesterolemic
0,638  0,009  Cardiovascular analeptic
0,620  0,019  CYP2C9 substrate
0,603  0,002  Lipocortins synthesis antagonist
0,602  0,003  Psychosexual dysfunction treatment
0,610  0,011  Proliferative diseases treatment
0,610  0,012  Immunosuppressant
0,580  0,020  Prostate cancer treatment
0,562  0,005  UGT2B4 substrate
0,563  0,016  Cytotoxic
0,553  0,015  Hepatic disorders treatment
0,549  0,014  NOS2 expression inhibitor
0,528  0,004  UGT2B7 substrate
0,536  0,016  AR expression inhibitor
0,522  0,006  Prostatic (benign) hyperplasia treatment
0,520  0,003  Sodium/bile acid cotransporter inhibitor
0,508  0,003  UGT2B9 substrate
0,520  0,016  Antineoplastic (non-small cell lung cancer)
0,509  0,012  UGT1A6 substrate
0,502  0,005  Contraceptive
0,512  0,018  Chemopreventive
0,497  0,004  UGT2B15 substrate
0,515  0,025  Antineoplastic (ovarian cancer)
0,482  0,005  Prostate disorders treatment
0,479  0,004  Antipruritic, non-allergic
0,487  0,014  Antineoplastic (lymphoma)
0,491  0,022  Antineoplastic (pancreatic cancer)
0,484  0,026  Immunomodulator
0,456  0,004  Neurotrophic factor enhancer
0,463  0,014  Antineoplastic (liver cancer)
0,460  0,012  UGT1A1 substrate
0,467  0,026  Lipoprotein disorders treatment
0,452  0,016  Antihypertriglyceridemic
0,445  0,015  Antineoplastic (renal cancer)
0,450  0,025  Metabolic disease treatment
0,468  0,050  Antibacterial
0,420  0,013  Abortion inducer
0,437  0,033  Antineoplastic (melanoma)
0,408  0,010  Interferon gamma antagonist
0,418  0,031  UGT1A9 substrate
0,395  0,014  Hepatoprotectant
0,456  0,080  Caspase 9 stimulant
0,414  0,039  CYP2C19 substrate
0,375  0,006  Antineoplastic antibiotic
0,381  0,013  Anesthetic
0,403  0,038  Apoptosis antagonist
0,395  0,042  ICAM1 expression inhibitor
0,367  0,021  Anesthetic general
0,356  0,015  Antiacne
0,339  0,008  Cholesterol synthesis inhibitor
0,356  0,029  DNA synthesis inhibitor
0,360  0,035  Hypoglycemic
0,324  0,005  Contraceptive male
0,319  0,006  Androgen antagonist
0,313  0,004  UGT2B10 substrate
0,326  0,016  Hair growth stimulant
0,362  0,057  Antifungal
0,299  0,002  Arachidonic acid antagonist
0,310  0,018  Lipid peroxidase inhibitor
0,306  0,014  Interleukin 6 antagonist
0,331  0,049  Chemoprotective
0,349  0,068  Antiallergic
0,327  0,047  Antineoplastic (endocrine cancer)
0,314  0,035  Antineoplastic (sarcoma)
0,355  0,085  Antiobesity
0,269  0,004  Androgen agonist
0,318  0,055  Antioxidant
0,320  0,062  Cardioprotectant
0,261  0,006  Microtubule formation inhibitor
0,273  0,020  Antiviral (Influenza A)
0,300  0,049  Angiogenesis stimulant
0,311  0,061  Hypoxia-inducible factor 1 alpha inhibitor
0,259  0,011  Neurotrophic factor
0,246  0,002  Anabolic
0,245  0,002  RNA-directed RNA polymerase stimulant
0,242  0,002  UGT2B11 substrate
0,247  0,009  Contraceptive female
0,242  0,003  Anticholelithogenic
0,249  0,012  Farnesoid X receptor antagonist
0,243  0,007  Growth stimulant
0,303  0,071  Interleukin 2 agonist
0,268  0,036  P-glycoprotein inhibitor
0,282  0,056  Cytostatic
0,238  0,019  VEGF expression inhibitor
0,311  0,093  Antiprotozoal (Plasmodium)
0,231  0,014  Antieczematic
0,219  0,003  Glucocorticoid antagonist
0,257  0,047  Platelet adhesion inhibitor
0,269  0,059  Hypolipemic
0,238  0,051  Antiviral (Influenza)
0,189  0,003  Na+ K+ transporting ATPase inhibitor
0,201  0,020  Endometrios treatment
0,235  0,058  Carcinogenic
0,202  0,031  Antifungal enhancer
0,171  0,005  Glycine receptor antagonist
0,176  0,020  Antineoplastic alkaloid
0,156  0,002  Lipocortins synthesis agonist
0,163  0,010  Estrogen agonist
0,271  0,123  Calcium channel activator
0,197  0,052  UGT1A3 substrate
0,157  0,013  SULT1E1 substrate
0,169  0,025  Alcohol dehydrogenase substrate
0,152  0,010  Antiprotozoal activity enhancer
0,158  0,018  Antibiotic
0,249  0,110  CTGF expression inhibitor
0,162  0,024  Sulfotransferase substrate
0,143  0,007  5-Alpha-reductase inhibitor
0,249  0,114  Bone diseases treatment
0,135  0,002  Glucocorticoid agonist
0,158  0,029  Choleretic
0,155  0,027  Antineoplastic, alkylator
0,231  0,103  Antiosteoporotic
0,181  0,060  Toxic, respiratory center
0,225  0,107  Immunostimulant
0,158  0,040  Pregnane X receptor agonist
0,128  0,010  Glycine receptor agonist
0,263  0,152  Antiprotozoal
0,200  0,091  Cardiodepressant
0,121  0,014  Postmenopausal disorders treatment
0,136  0,031  Estrogen antagonist
0,102  0,002  Corticosteroid-like
0,098  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,109  0,020  Aromatase inhibitor
0,102  0,014  Antitreponemal
0,097  0,009  Estrogen receptor alpha agonist
0,113  0,027  Bile acid receptor antagonist
0,141  0,056  Antihyperlipoproteinemic
0,126  0,042  UGT2B1 substrate
0,095  0,011  SULT2A1 substrate
0,214  0,132  Antihypoxic
0,146  0,070  Adenylate cyclase stimulant
0,152  0,079  Melanin inhibitor
0,164  0,092  LDLR expression enhancer
0,121  0,050  Expectorant
0,082  0,012  Postcoital contraceptive
0,131  0,061  DNA polymerase I inhibitor
0,186  0,119  Peptidyltransferase inhibitor
0,070  0,004  Cholesterol absorption inhibitor
0,080  0,014  Estrogen receptor beta agonist
0,142  0,081  NOS3 expression enhancer
0,190  0,130  Interleukin agonist
0,079  0,020  Protein 50S ribosomal subunit inhibitor
0,108  0,049  Estrogen receptor beta antagonist
0,123  0,065  Alkylator
0,096  0,043  Transcription factor NF kappa B stimulant
0,068  0,015  Aldosterone antagonist
0,063  0,011  Microtubule stabilization
0,067  0,017  Anesthetic inhalation
0,066  0,016  Mineralocorticoid receptor antagonist
0,058  0,010  Hypogonadism treatment
0,134  0,089  Antifungal (Cryptococcus)
0,050  0,005  Progesterone agonist
0,060  0,015  Progesterone antagonist
0,168  0,123  Antineoplastic enhancer
0,065  0,021  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,048  0,003  Hedgehog signaling activator
0,053  0,013  Farnesoid X receptor agonist
0,204  0,164  Caspase 3 stimulant
0,082  0,046  Estrogen receptor alpha antagonist
0,045  0,010  HMG CoA reductase inhibitor
0,147  0,113  Phospholipase C inhibitor
0,054  0,020  Liver X receptor agonist
0,031  0,009  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,067  0,048  Andropause treatment
0,114  0,095  Skin whitener
0,128  0,110  Growth hormone agonist
0,019  0,001  Transcortin receptor antagonist
0,036  0,020  Tubulin agonist
0,139  0,123  Antihelmintic
0,056  0,040  Acetyl-CoA transferase 2 inhibitor
0,024  0,012  Vitamin D receptor antagonist
0,131  0,120  Antipruritic
0,078  0,067  Antiviral (Trachoma)
0,021  0,011  Apical sodium codependent bile acid transporter inhibitor
0,165  0,157  Cardiotonic
0,085  0,077  Vascular dementia treatment
0,094  0,087  Mucolytic
0,087  0,079  Dementia treatment
0,016  0,014  Telomerase stimulant
0,109  0,107  Protein kinase stimulant
0,019  0,018  Estrone sulfatase inhibitor
0,012  0,011  Antibiotic Macrolide-like
0,057  0,057  Heme oxygenase stimulant
0,015  0,015  Vitamin D receptor agonist

